I will update this article I just wanted to get the idea down because this is capable of 2-5 x in short amount of time..
So rough notes but wanted to have it documented real time this is just the basics you should research collaboration with MERCK Parkinson and other pipeline
Start your DD
Read the March 13 Highlights
ir.intecpharma.com/n...r-end-2019-financial
Highlights from the Quarter and Recent Weeks
Developed an Accordion Pill (AP) for a Merck & Co. (MSD) proprietary compound that met the in vitro specifications set forth in the companies' research collaboration and are now in discussions with MSD to determine advancing the program into human pharmacokinetic (PK) studies;
Concluded the Feasibility and Option Agreement (FOA) with Novartis Pharmaceuticals, under which Intec Pharma built a custom-designed AP for a Novartis proprietary compound that met the technical and PK clinical specifications set forth but following an internal and revised commercial strategic assessment, Novartis determined not to take the program forward;
Novartis agreed to pay Intec Pharma$1.5 million upon conclusion of the program FOA and those funds were transferred to the Company in February 2020;
Completed the qualifying production runs for the commercial scale manufacturing of AP Carbidopa/Levodopa (AP-CD/LD) with our manufacturing partner, LTS Lohmann Therapie-Systeme AG (LTS);
Secured $10 million in committed financing from Aspire Capital, a long-term institutional investor; and
(Lets face it we just dealt with a great market #COVID plunge or we would never see these levels for this company)
The current .20 .23 handle is a steep discount the recent PP done at .40 .
This means there will be great incentive for those participants to see a much higher handle then today's current price.
You also have a serious bullish chart with confirmation coming for a massive upward reversal
Expect to see this rebound well over the recent .40 PP price..
For a swing trade .
So rough notes but wanted to have it documented real time this is just the basics you should research collaboration with MERCK Parkinson and other pipeline
Start your DD
Read the March 13 Highlights
ir.intecpharma.com/n...r-end-2019-financial
Highlights from the Quarter and Recent Weeks
Developed an Accordion Pill (AP) for a Merck & Co. (MSD) proprietary compound that met the in vitro specifications set forth in the companies' research collaboration and are now in discussions with MSD to determine advancing the program into human pharmacokinetic (PK) studies;
Concluded the Feasibility and Option Agreement (FOA) with Novartis Pharmaceuticals, under which Intec Pharma built a custom-designed AP for a Novartis proprietary compound that met the technical and PK clinical specifications set forth but following an internal and revised commercial strategic assessment, Novartis determined not to take the program forward;
Novartis agreed to pay Intec Pharma$1.5 million upon conclusion of the program FOA and those funds were transferred to the Company in February 2020;
Completed the qualifying production runs for the commercial scale manufacturing of AP Carbidopa/Levodopa (AP-CD/LD) with our manufacturing partner, LTS Lohmann Therapie-Systeme AG (LTS);
Secured $10 million in committed financing from Aspire Capital, a long-term institutional investor; and
(Lets face it we just dealt with a great market #COVID plunge or we would never see these levels for this company)
The current .20 .23 handle is a steep discount the recent PP done at .40 .
This means there will be great incentive for those participants to see a much higher handle then today's current price.
You also have a serious bullish chart with confirmation coming for a massive upward reversal
Expect to see this rebound well over the recent .40 PP price..
For a swing trade .
Look for the 50 area gap and retest $NTEC